ABT1 Antibodies

Santa Cruz Biotechnology supplies a comprehensive collection of ABT1 monoclonal antibodies for investigating ABT1 in various biological processes. The monoclonal antibodies are validated for western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). ABT1, or Apoptosis Regulator Bcl-2, plays a critical role in the regulation of apoptosis, influencing cell survival and death pathways. Research has shown that ABT1 dysregulation can lead to uncontrolled cell proliferation, making it a significant focus in cancer studies. Understanding ABT1's molecular mechanisms and interactions provides valuable insights for developing targeted therapeutic approaches. ABT1 research continues to reveal new pathways and potential intervention points in disease treatment. Investigating ABT1's role in cellular processes helps illuminate complex biological mechanisms. Multiple detection methods allow researchers to thoroughly examine ABT1's expression patterns and interactions. Santa Cruz Biotechnology monoclonal antibodies support researchers worldwide in advancing scientific understanding of ABT1's role in health and disease.